Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)
China · Delayed Price · Currency is CNY 23.85
-0.31 (-1.28%)
Sep 26, 2025, 2:45 PM CST
SHA:600645 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 72.94 | 100.35 | 106.45 | 112.99 | 155.32 | -126.86 | Upgrade |
Depreciation & Amortization | 128.3 | 133.4 | 143.6 | 138.21 | 124.62 | 103.31 | Upgrade |
Other Amortization | 40.8 | 36.67 | 29.02 | 26.12 | 23.09 | 24.33 | Upgrade |
Loss (Gain) From Sale of Assets | -0.23 | -1.3 | -3.67 | -2.03 | -1.49 | -21.24 | Upgrade |
Asset Writedown & Restructuring Costs | 4.84 | 4.68 | 0.31 | 0.8 | 27.64 | 265.48 | Upgrade |
Loss (Gain) From Sale of Investments | 39.79 | 44.33 | 47.94 | 8.71 | -85.87 | -45.51 | Upgrade |
Provision & Write-off of Bad Debts | 30.25 | 27.68 | 20.9 | 17.63 | 38.21 | 18.12 | Upgrade |
Other Operating Activities | -1.73 | 3.12 | 2.09 | -2.04 | -5.18 | 1.09 | Upgrade |
Change in Accounts Receivable | 24.26 | -31.23 | -12.23 | -31.93 | 30.73 | 67.71 | Upgrade |
Change in Inventory | 6.97 | -0.63 | -9.25 | -27.64 | -4.56 | -5.88 | Upgrade |
Change in Accounts Payable | -16.28 | -11.18 | -1.07 | 35.06 | 19.42 | -29.76 | Upgrade |
Change in Other Net Operating Assets | -0.03 | -0.03 | 12.21 | -6.68 | -19.46 | - | Upgrade |
Operating Cash Flow | 309.59 | 285.19 | 299.02 | 261.89 | 320.96 | 244.35 | Upgrade |
Operating Cash Flow Growth | 8.74% | -4.62% | 14.18% | -18.40% | 31.35% | 1.19% | Upgrade |
Capital Expenditures | -49.87 | -67.32 | -88.61 | -99.19 | -127.74 | -91.72 | Upgrade |
Sale of Property, Plant & Equipment | 0.52 | 0.78 | 0.19 | 1.42 | 12.63 | 11.57 | Upgrade |
Cash Acquisitions | - | - | - | - | - | 0.24 | Upgrade |
Divestitures | - | - | - | - | - | -0.77 | Upgrade |
Investment in Securities | -609.48 | 1.95 | -2.06 | -0.57 | -18.95 | 379.9 | Upgrade |
Other Investing Activities | 5.05 | 0.72 | - | - | - | 8.87 | Upgrade |
Investing Cash Flow | -653.78 | -63.86 | -90.49 | -98.34 | -134.05 | 308.09 | Upgrade |
Long-Term Debt Issued | - | - | - | - | - | 13.2 | Upgrade |
Long-Term Debt Repaid | - | -41.19 | -35.76 | -41.33 | -29.13 | -105.04 | Upgrade |
Net Debt Issued (Repaid) | -52.08 | -41.19 | -35.76 | -41.33 | -29.13 | -91.84 | Upgrade |
Repurchase of Common Stock | -32.33 | -200.03 | - | - | - | -0.32 | Upgrade |
Common Dividends Paid | - | - | - | - | -1.61 | -4.02 | Upgrade |
Other Financing Activities | -37.31 | -43.69 | 17.03 | 33.58 | -18.97 | -8.79 | Upgrade |
Financing Cash Flow | -121.72 | -284.91 | -18.73 | -7.75 | -49.71 | -104.96 | Upgrade |
Foreign Exchange Rate Adjustments | 1.31 | 7.3 | 10.22 | 35.3 | -7.44 | -18.86 | Upgrade |
Net Cash Flow | -464.6 | -56.28 | 200.02 | 191.1 | 129.75 | 428.63 | Upgrade |
Free Cash Flow | 259.72 | 217.87 | 210.4 | 162.7 | 193.22 | 152.64 | Upgrade |
Free Cash Flow Growth | 31.47% | 3.55% | 29.32% | -15.79% | 26.59% | 28.77% | Upgrade |
Free Cash Flow Margin | 17.32% | 13.74% | 13.23% | 10.46% | 12.58% | 11.57% | Upgrade |
Free Cash Flow Per Share | 0.59 | 0.48 | 0.46 | 0.35 | 0.41 | 0.33 | Upgrade |
Cash Interest Paid | 0.25 | 0.59 | 0.92 | 1.27 | - | - | Upgrade |
Cash Income Tax Paid | 152.9 | 162.15 | 170.94 | 110.96 | 116.78 | 97.19 | Upgrade |
Levered Free Cash Flow | 247.65 | 189.08 | 164.65 | 141.27 | 197.98 | 139.62 | Upgrade |
Unlevered Free Cash Flow | 250.47 | 192.22 | 167.79 | 143.78 | 199.95 | 141.97 | Upgrade |
Change in Working Capital | -5.36 | -63.75 | -47.63 | -38.49 | 44.62 | 25.63 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.